The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

PHASE2TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

November 14, 2024

Study Completion Date

February 28, 2025

Conditions
Hemophilia aHemophilia B
Interventions
DRUG

SerpinPC

Administered as SC injection.

Trial Locations (59)

14

Yeolyan Hematology and Oncology Center, MoH of Armenia CJSC, Yerevan

1000

Kocaeli Universitesi Tip Fakultesi, Izmir

1020

Queen Fabiola Children, Brussels

1200

Cliniques Universitaires Saint-Luc, Brussels

1307

Universitätsklinikum Carl Gustav Carus Dresden, Dresden

2050

Royal Prince Alfred Hospital, Camperdown

3004

The Alfred Hospital, Melbourne

6001

Phoenix Pharma Pty Ltd, Port Elizabeth

8035

Hospital Universitari Vall d'Hebron, Barcelona

10004

National Taiwan University Hospital, Taipei

10126

A.O.U Citt della Salute e della Scienza di Torino, Torino

10249

Klinik fur Angiologie Hamostaseologie Haus 12 A Gerinnungssprechstunde, Berlin

11217

Taipei Veterans General Hospital, Taipei

15213

Hemophilia Center of Western Pennsylvania, Pittsburgh

17033

Penn State Hershey Medical Center, Hershey

20122

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan

22030

Trakya University Haematology Clinic, Edirne

27834

East Carolina Univeristy, Greenville

29010

Hospital Regional Universitario de Malaga Hospital Carlos Haya - Hospital Materno-Infantil, Málaga

30120

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia

33100

Presidio Ospedaliero Universitario S. Maria della Misericordia - ASUFC, Udine

33612

University of South Florida, Tampa

34093

Istanbul University Oncology Institute, Istanbul

35100

Ege University Medical Faculty Pediatric Hospital, Izmir

Ege University Hospital Internal Disease, Izmir

37126

Azienda Ospedaliera Universitaria Integrata Verona, Verona

40447

China Medical University Hospital, Taichung

40705

Taichung Veterans General Hospital, Taichung

46260

Indiana Hemophilia and Thrombosis Center, Inc., Indianapolis

48109

University of Michigan, Ann Arbor

50009

Hospital Universitario Miguel Servet, Zaragoza

50134

Azienda Ospedaliero-Universitaria Careggi, Florence

52246

University of Iowa Healthcare, Iowa City

55200

Ondokuz Mayis University Medical Faculty, Samsun

55455

University of Minnesota Medical Center, Minneapolis

60590

University Hospital Frankfurt, Frankfurt am Main

69500

Hospices Civils de Lyon (HCL) - Hopital Femme-Mere-Enfant (HFME), Lyon

75015

Hopital Necker - Enfants Malades, Paris

77030

University of Texas Health Science Center at Houston-Gulf States HTC, Houston

94270

Hôpital Bicêtre, Le Kremlin-Bicêtre

141008

Christian Medical College & Hospital, Ludhiana

400022

K J Somaiya Super Speciality Hospital & Research Centre, Mumbai

80045-7202

University of Colorado School of Medicine, Aurora

L8S 4K1

Hamilton Health Sciences Corporation, Hamilton

L8S4K1

Hamilton Health Sciences Corporation, Hamilton

M5B 1W8

Unity Health Toronto, Toronto

35-302

Korczowski Bartosz, Gabinet Lekarski, Rzeszów

50-367

Kl Hemat Now Krwi i Trans USK, Wroclaw

Unknown

Hospital Universitario La Paz, Madrid

B15 2GW

University Hospitals Birmingham NHS Foundation Trust, Birmingham

CF14 4XW

University Hospital of Wales, Cardiff

G4 0SF

Glasgow Royal Infirmary, Glasgow

CT1 3NG

Kent Canterbury Hospital, Canterbury

E1 2AT

Barts and London School of Medicine and Dentistry, London

NW3 2QG

Royal Free London NHS Foundation Trust, London

W2 1NY

Imperial College Healthcare NHS Trust, London

OX3 9DU

Oxford University Hospital, Oxford

S016 6YD

Southampton General Hospital, Southampton

NE1 4LP

Royal Victoria Infirmary, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Centessa Pharmaceuticals plc

INDUSTRY

lead

ApcinteX Ltd

INDUSTRY